shc014748m
Small moleculeexperimental
Clinical trial activity
4 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Sep 7, 2018 (NCT03588598)
Timeline
Indications
Mechanism of action
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04470141 | Phase 2 | Aug 31, 2020 | Nanjing Sanhome Pharmaceutical, Co., Ltd. |
| NCT04431089 | Phase 2 | Jun 30, 2020 | Nanjing Medical University, Nanjing Sanhome Pharmaceutical, Co., Ltd. |
| NCT04006860 | Phase 1 | Jul 31, 2019 | Nanjing Sanhome Pharmaceutical, Co., Ltd. |
| NCT03588598 | Phase 1 | Sep 7, 2018 | Nanjing Medical University, Nanjing Sanhome Pharmaceutical, Co., Ltd., Zhejiang University |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Nanjing Sanhome Pharmaceutical, Co., Ltd. | For profit | 4 | 4 | 2 | 2018 |
| Nanjing Medical University | Academic/Hospital | 2 | 0 | 2 | 2018 |
| Zhejiang University | Academic/Hospital | 1 | 0 | 1 | 2018 |
3 organizations
Page 1 / 1